Sign In

Antiretroviral Therapy.

HIV Question Bank

Evaluation and Management of Virologic FailureQuestion 1/10

Questions in Topic

A 24-year-old man with moderate baseline renal insufficiency is seen in clinic for a routine follow-up visit. He describes having problems consistently taking the antiretroviral regimen rilpivirine-tenofovir alafenamide-emtricitabine. Laboratory studies are ordered and show an HIV RNA level of 875 copies/mL, which is an increase from the last visit when it was undetectable.

At this point, which one of the following is the best choice regarding HIV drug-resistance testing for this patient?

Figure 1. Indications for HIV Drug Resistance Testing
Source: Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. Department of Health and Human Services. Laboratory testing: drug-resistance testing. March 23, 2023.
Prev  Skip

Sign In or Register Progress Not Saved!
Since you are not signed in, your progress won't be saved.
Question Last Updated
February 1st, 2025

Steps to Acquire CE for this Question Bank Topic:

1

Answer

Answer all questions
2

Score 80%+

Answer correctly
3

Claim CE

Choose CNE or CME
4

Give Feedback

Complete survey
5

Print Certificate

Obtain proof of CE

This question requires improvement because:


Comment further on how to improve this question or summary:



Since you've received 80% or better on this quiz, you may claim continuing education credit.

You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.